logo

For the Inventor, By the Inventor

Scarsdale, NY, United States of America

Pankaj Gupta

This inventor holds 20 USPTO granted patents and 8 published patent applications and 4 EPO patents, primarily in Cancer Treatment. Top assignees: Boehringer Ingelheim International Gmbh, Macrogenics, Inc., Cdr-Life Ag. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pankaj Gupta. Retrieved from https://idiyas.com/inventor/pankaj-gupta-0xvt2zen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal20 out of 1,562 
 
Boehringer Ingelheim International Gmbh
 patents
silverMedal3 out of 133 
 
Macrogenics, Inc.
 patents
bronzeMedal1 out of 4 
 
Cdr-Life Ag
 patents
4. 1 out of 1 
 
Ose Immmnotherapeatics Sa
 patent
where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-Neuropilin 1A Antibodies
Multi-Specific Binding Proteins
Cancer Treatment
Bispecific Antibodies
Tri-Specific Binding Molecules
Anti-SIRP-Alpha Antibodies
Anti-C3 Antibodies
IL-23A Targeting Compounds
BAFF Antibodies
Anti-PD-1 Antibodies
CD137 Molecules
FAP Molecules
20 patents (USPTO):Explore Patents
1. 12540187 - METHOD OF TREATING VASCULAR EYE AND RETINAL DISEASES BY ADMINISTRATION OF ANTI-NEUROPILIN 1A ANTIBODIES (2026-02-03),
2. 12528879 - MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT (2026-01-20),
3. 12516127 - ANTI-SIRP-ALPHA ANTIBODIES (2026-01-06),
4. 12344663 - Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases (2025-07-01),
5. 12312405 - Anti-PD-1 antibodies (2025-05-27),
6. 12275798 - Tri-specific binding molecules (2025-04-14),
7. 12173083 - Multi-specific binding proteins for cancer treatment (2024-12-24),
8. 12146000 - Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer (2024-11-19),
9. 11884744 - Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof (2024-01-30),
10. 11795219 - Antibody molecules for cancer treatment (2023-10-24),
11. 11732045 - Multi-specific binding proteins for cancer treatment (2023-08-22),
12. 11661458 - Anti-NRP1A antibodies and their uses for treating eye or ocular diseases (2023-05-30),
13. 11572412 - Anti-SIRP-alpha antibodies (2023-02-07),
14. 11396539 - Anti-ANGPT2 antibodies (2022-07-26),
15. 11370818 - Anti-BAFF antibodies (2022-06-28),

Title: Pankaj Gupta: Innovator in Antibody Therapeutics

Introduction

Pankaj Gupta is a prominent inventor based in Scarsdale, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 17 patents to his name, Gupta's work focuses on innovative solutions for treating various diseases.

Latest Patents

Among his latest patents are the "Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases." This invention relates to antibodies that specifically target complement C3, providing new methods for treating ocular diseases. Another notable patent is for "Anti-PD-1 antibodies," which involves new anti-PD-1 antibodies and their fragments for therapeutic and diagnostic applications. These inventions highlight Gupta's commitment to advancing medical science through innovative antibody therapies.

Career Highlights

Pankaj Gupta has worked with leading companies in the biotechnology sector, including Boehringer Ingelheim International GmbH and Macrogenics, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in antibody therapeutics.

Collaborations

Gupta has collaborated with notable professionals in his field, including Philip Nicholas Gorman and Priyanka Gupta. These partnerships have further enhanced his research and innovation capabilities.

Conclusion

Pankaj Gupta is a distinguished inventor whose work in antibody therapeutics has the potential to transform treatment options for various diseases. His innovative patents and collaborations reflect his dedication to advancing healthcare through scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…